An effort to build a first-of-its kind, drug-discovery company in Cleveland is coming together behind a confluence of cash and expertise.
BioMotiv, a biotech startup launched last year from University Hospitals, has already raised $46 million in operating capital--toward a goal of $100 million. Today it will announce a partnership with a California drug developer with global reach.
Image Courtesy of marin / FreeDigitalPhotos.net
To read the full, original article click on this link: Cleveland drug-discovery company BioMotiv attracts new millions and a key partner | cleveland.com
